247 related articles for article (PubMed ID: 29992976)
21. Design, synthesis, and evaluation of a novel sequence-selective epoxide-containing DNA cross-linking agent based on the pyrrolo[2, 1-c][1,4]benzodiazepine system.
Wilson SC; Howard PW; Forrow SM; Hartley JA; Adams LJ; Jenkins TC; Kelland LR; Thurston DE
J Med Chem; 1999 Oct; 42(20):4028-41. PubMed ID: 10514273
[TBL] [Abstract][Full Text] [Related]
22. TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumors.
Gymnopoulos M; Betancourt O; Blot V; Fujita R; Galvan D; Lieuw V; Nguyen S; Snedden J; Stewart C; Villicana J; Wojciak J; Wong E; Pardo R; Patel N; D'Hooge F; Vijayakrishnan B; Barry C; Hartley JA; Howard PW; Newman R; Coronella J
Mol Oncol; 2020 Jan; 14(1):54-68. PubMed ID: 31736230
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and evaluation of new noncross-linking pyrrolobenzodiazepine dimers with efficient DNA binding ability and potent antitumor activity.
Kamal A; Ramesh G; Laxman N; Ramulu P; Srinivas O; Neelima K; Kondapi AK; Sreenu VB; Nagarajaram HA
J Med Chem; 2002 Oct; 45(21):4679-88. PubMed ID: 12361394
[TBL] [Abstract][Full Text] [Related]
24. The use of molecular dynamics simulations to evaluate the DNA sequence-selectivity of G-A cross-linking PBD-duocarmycin dimers.
Jackson PJM; Rahman KM; Thurston DE
Bioorg Med Chem Lett; 2017 Jan; 27(1):102-108. PubMed ID: 27889454
[TBL] [Abstract][Full Text] [Related]
25. The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136.
Clingen PH; De Silva IU; McHugh PJ; Ghadessy FJ; Tilby MJ; Thurston DE; Hartley JA
Nucleic Acids Res; 2005; 33(10):3283-91. PubMed ID: 15944449
[TBL] [Abstract][Full Text] [Related]
26. Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody-Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer.
Gregson SJ; Pugh K; Patel N; Afif-Rider S; Vijayakrishnan B; Santos K; Riedl J; Hutchinson I; Kang GD; Chooi KP; Beard R; Adams L; Barry CS; Ball K; Masterson LA; McFarlane M; Hartley JA; Howard PW
Mol Cancer Ther; 2022 Sep; 21(9):1439-1448. PubMed ID: 35793464
[TBL] [Abstract][Full Text] [Related]
27. Effect of base sequence on the DNA cross-linking properties of pyrrolobenzodiazepine (PBD) dimers.
Rahman KM; James CH; Thurston DE
Nucleic Acids Res; 2011 Jul; 39(13):5800-12. PubMed ID: 21427082
[TBL] [Abstract][Full Text] [Related]
28. Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads.
Donnell AF; Zhang Y; Stang EM; Wei DD; Tebben AJ; Perez HL; Schroeder GM; Pan C; Rao C; Borzilleri RM; Vite GD; Gangwar S
Bioorg Med Chem Lett; 2017 Dec; 27(23):5267-5271. PubMed ID: 29102228
[TBL] [Abstract][Full Text] [Related]
29. DNA interstrand cross-linking and in vivo antitumor activity of the extended pyrrolo[2,1-c][1,4]benzodiazepine dimer SG2057.
Hartley JA; Hamaguchi A; Suggitt M; Gregson SJ; Thurston DE; Howard PW
Invest New Drugs; 2012 Jun; 30(3):950-8. PubMed ID: 21384134
[TBL] [Abstract][Full Text] [Related]
30. Antibody-Drug Conjugates with Indolinobenzodiazepine Dimer Payloads: DNA-Binding Mechanism of Indolinobenzodiazepine Dimer Catabolites in Target Cancer Cells.
Singh R; Reid EE; Harris L; Salomon PL; Miller ML; Chari RVJ; Keating TA
Mol Pharm; 2020 Jan; 17(1):50-58. PubMed ID: 31742408
[TBL] [Abstract][Full Text] [Related]
31. Effects of Systematic Shortening of Noncovalent C8 Side Chain on the Cytotoxicity and NF-κB Inhibitory Capacity of Pyrrolobenzodiazepines (PBDs).
Corcoran DB; Lewis T; Nahar KS; Jamshidi S; Fegan C; Pepper C; Thurston DE; Rahman KM
J Med Chem; 2019 Feb; 62(4):2127-2139. PubMed ID: 30688457
[TBL] [Abstract][Full Text] [Related]
32. Targeting CD19-positive lymphomas with the antibody-drug conjugate loncastuximab tesirine: preclinical evidence as single agent and in combination therapy.
Tarantelli C; Wald D; Munz N; Spriano F; Bruscaggin A; Cannas E; Cascione L; Gaudio E; Arribas AJ; Manjappa S; Golino G; Scalise L; Cacciapuoti MT; Zucca E; Stathis A; Inghirami G; Van Berkel PH; Rossi D; Caimi PF; Zammarchi F; Bertoni F
Haematologica; 2024 May; ():. PubMed ID: 38721745
[TBL] [Abstract][Full Text] [Related]
33. SG2285, a novel C2-aryl-substituted pyrrolobenzodiazepine dimer prodrug that cross-links DNA and exerts highly potent antitumor activity.
Hartley JA; Hamaguchi A; Coffils M; Martin CR; Suggitt M; Chen Z; Gregson SJ; Masterson LA; Tiberghien AC; Hartley JM; Pepper C; Lin TT; Fegan C; Thurston DE; Howard PW
Cancer Res; 2010 Sep; 70(17):6849-58. PubMed ID: 20660714
[TBL] [Abstract][Full Text] [Related]
34. DNA interstrand crosslinking agents: synthesis, DNA interactions, and cytotoxicity of dimeric achiral seco-amino-CBI and conjugates of achiral seco-amino-CBI with pyrrolobenzodiazepine (PBD).
Purnell B; Sato A; O'kelley A; Price C; Summerville K; Hudson S; O'hare C; Kiakos K; Asao T; Lee M; Hartley JA
Bioorg Med Chem Lett; 2006 Nov; 16(21):5677-81. PubMed ID: 16919946
[TBL] [Abstract][Full Text] [Related]
35. Pyrrolobenzodiazepine dimers: novel sequence-selective, DNA-interactive, cross-linking agents with activity against Gram-positive bacteria.
Hadjivassileva T; Thurston DE; Taylor PW
J Antimicrob Chemother; 2005 Sep; 56(3):513-8. PubMed ID: 16024592
[TBL] [Abstract][Full Text] [Related]
36. Analogues of DNA minor groove cross-linking agents incorporating aminoCBI, an amino derivative of the duocarmycins: Synthesis, cytotoxicity, and potential as payloads for antibody-drug conjugates.
Giddens AC; Lee HH; Lu GL; Miller CK; Guo J; Lewis Phillips GD; Pillow TH; Tercel M
Bioorg Med Chem; 2016 Nov; 24(22):6075-6081. PubMed ID: 27745990
[TBL] [Abstract][Full Text] [Related]
37. Pyrrolobenzodiazepine Dimer Antibody-Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers.
Gregson SJ; Masterson LA; Wei B; Pillow TH; Spencer SD; Kang GD; Yu SF; Raab H; Lau J; Li G; Lewis Phillips GD; Gunzner-Toste J; Safina BS; Ohri R; Darwish M; Kozak KR; Dela Cruz-Chuh J; Polson A; Flygare JA; Howard PW
J Med Chem; 2017 Dec; 60(23):9490-9507. PubMed ID: 29112410
[TBL] [Abstract][Full Text] [Related]
38. Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life Extension.
Li Q; Barrett A; Vijayakrishnan B; Tiberghien A; Beard R; Rickert KW; Allen KL; Christie RJ; Marelli M; Harper J; Howard P; Wu H; Dall'Acqua WF; Tsui P; Gao C; Borrok MJ
Bioconjug Chem; 2019 Apr; 30(4):1232-1243. PubMed ID: 30912649
[TBL] [Abstract][Full Text] [Related]
39. Sequence-selective recognition of duplex DNA through covalent interstrand cross-linking: kinetic and molecular modeling studies with pyrrolobenzodiazepine dimers.
Smellie M; Bose DS; Thompson AS; Jenkins TC; Hartley JA; Thurston DE
Biochemistry; 2003 Jul; 42(27):8232-9. PubMed ID: 12846572
[TBL] [Abstract][Full Text] [Related]
40. Antibody Drug Conjugates Differentiate Uptake and DNA Alkylation of Pyrrolobenzodiazepines in Tumors from Organs of Xenograft Mice.
Ma Y; Khojasteh SC; Hop CE; Erickson HK; Polson A; Pillow TH; Yu SF; Wang H; Dragovich PS; Zhang D
Drug Metab Dispos; 2016 Dec; 44(12):1958-1962. PubMed ID: 27683653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
